NEW YORK (GenomeWeb News) — PerkinElmer yesterday said it has acquired the remaining interest in PerkinElmer India from Labindia Instruments for an undisclosed sum.
The company also said it plans to open a new headquarters and a new technical support and applications center in Mumbai later this year.
PerkinElmer India is a sales, service, and marketing branch aimed at India’s biotechnology sector. The acquisition makes PerkinElmer India a wholly owned PerkinElmer subsidiary, the company said.
PerkinElmer CEO Gregory Summe said this deal shows the company’s commitment “to accelerate growth in the country’s rapidly expanding health sciences market.”
PerkinElmer India currently employs 170 people.
Financial terms of the deal were not disclosed.